NCT05858424
See how this trial matches your record
Connect MyChart to see which criteria your record clearly satisfies, which need a clinician’s review, and which appear to disqualify you. Your data is read in this browser tab and never sent to our servers.
Finishing cancer treatment is often a time of relief, but it can also bring feelings of anxiety or uncertainty as you transition back to daily life. This study is exploring whether a specialized "end-of-treatment day hospital" can improve the quality of life for adolescents and young adults during their first year of recovery. If you participate, you will be randomly assigned to either receive your usual follow-up care or to attend this additional one-day multidisciplinary clinic. This clinic includes dedicated sessions with a doctor to summarize your care and create an "after-cancer plan," a psychologist to discuss your emotional needs, and a social worker to help you navigate returning to school or work. Depending on your needs, you might also meet with experts in nutrition or physical activity.
To be eligible for this study, you must have been between 15 and 25 years old at the time of your diagnosis and have received treatment for a solid tumor or lymphoma at IHOPe or the Leon Berard center. You must be in complete remission and have finished your last treatment—including maintenance therapy—within the past two months. Participation involves completing quality-of-life surveys over the course of a year so researchers can compare the two groups. Before joining, you should talk with your doctor about how this day hospital fits into your existing follow-up schedule and what emotional or social support you feel you need most right now.
Generated · Written by an AI model from the trial’s public ClinicalTrials.gov record. Not medical advice.
Rational: 800 cases of cancer per year are diagnosed in France among Adolescents and Young Adults (AYA). This population has been specifically targeted since 2008 by the INCa, leading to the development of structures entirely dedicated to its management. Indeed, the occurrence of cancer in this period of transition leads to specific problems, which require a special attention. The various measures taken since then (Cancer Plan 2014-2019, DGOS instruction in 2016, 10-year strategy to fight cancer 2021-2030) have enabled the implementation of multidisciplinary structures, resulting in better access to care, and consideration of the social, family and relational dimensions of this population. However, the transition from the end of oncology treatment to the follow-up period remains a sensitive period, generating both positive (relief, joy) and negative feelings (uncertainty, feelings of abandonment, anxiety). The investigators therefore hypothesize that the creation of a multidisciplinary end-of-treatment day hospital (DH) involving at least one medical interview, one psychological consultation and one social interview, would improve the quality of life of these former patients during the first year of oncology follow-up. Method: This is a clinical research study conducted in a single centre. At their last visit for treatment, the study will be offered to patients. If the participants agree to participate, they will be randomized to benefit from DH in addition to their planned follow-up with their oncologist. The main objective is to compare the quality of life of former patients according to participation in DH or not. 210 patients will be included for a 20-month recruitment period. Expected results: Throughout the development of DH, the investigators plan to improve the quality of life of former patients during this transitional phase.
Requires clinical discussion
Requires clinical discussion
Requires clinical discussion
Requires clinical discussion
Requires clinical discussion
Requires clinical discussion
Requires clinical discussion
Requires clinical discussion
Centre Leon Berard
Lyon, France
Amandine Bertrand, MD · +33478782606